Teladoc Health
TDOC
482 hedge funds and large institutions have $3.51B invested in Teladoc Health in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 143 increasing their positions, 181 reducing their positions, and 96 closing their positions.
37% more call options, than puts
Call options by funds: $318M | Put options by funds: $232M
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2.99% less ownership
Funds ownership: 88.46% → 85.48% (-3%)
12% less funds holding
Funds holding: 550 → 482 (-68)
21% less repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 181
26% less capital invested
Capital invested by funds: $4.74B → $3.51B (-$1.23B)
63% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 96
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$39.6M |
| 2 |
D.E. Shaw & Co
New York
|
+$33.3M |
| 3 |
BlackRock
New York
|
+$24.7M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$22.7M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$19.8M |
Top Sellers
TDOC Hedge Fund Activity: Q3 2022 in Review
482 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2022, worth a combined $3.51B — down 26% from $4.74B a quarter earlier.
Sellers outnumbered buyers: 96 funds closed out of TDOC and 36 opened new positions — a net loss of 60 holders — while 181 trimmed existing stakes and 143 added.
The largest buyer was State Street, adding an estimated $39.6M. The largest seller was Baillie Gifford & Co, cutting an estimated $87.5M.
- 482 institutional investors held Teladoc Health (TDOC) as of Q3 2022, down from 550 in Q2 2022.
- Funds reported $3.51B of Teladoc Health stock for Q3 2022, down 26% quarter-over-quarter.
- 36 funds opened new Teladoc Health positions in Q3 2022 and 96 closed out, a net change of -60 holders.
- The largest Teladoc Health buyer in Q3 2022 was State Street, an estimated $39.6M added.
- The largest Teladoc Health seller in Q3 2022 was Baillie Gifford & Co, an estimated $87.5M sold.
Based on aggregated 13F filings for Q3 2022.